ConocoPhillips Investing Cash Flow decreased by 230.4% to -$2.81B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 19.7%, from -$2.35B to -$2.81B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows relatively stable performance with a -1.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $532.00M | -$8.60B | -$611.00M | -$2.09B | -$3.11B | -$2.93B | -$1.45B | -$2.32B | -$2.38B | -$5.85B | -$2.14B | -$4.15B | -$2.66B | -$2.20B | -$2.35B | -$2.46B | -$3.18B | -$850.00M | -$2.81B |
| QoQ Change | — | — | <-999% | +92.9% | -242.2% | -48.5% | +5.5% | +50.6% | -59.9% | -2.9% | -145.5% | +63.4% | -93.9% | +36.0% | +17.2% | -6.6% | -4.9% | -29.2% | +73.3% | -230.4% |
| YoY Change | — | — | — | — | — | -683.6% | +65.9% | -137.0% | -10.8% | +23.2% | -99.5% | -47.9% | -79.2% | -11.5% | +62.4% | -9.6% | +40.7% | -19.6% | +61.4% | -19.7% |